OpenAlex
PricingAboutJobs
Log inGet started
Work

The effects of dapagliflozin on hepatic and visceral fat in type 2 diabetes patients with non‐alcoholic fatty liver disease

HTML

Year: 2021
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Journal of Gastroenterology and Hepatology
DOI: 10.1111/jgh.15580
Authors: Susrichit Phrueksotsai, Kanokwan Pinyopornpanish, Juntima Euathrongchit, Apinya Leerapun, Arintaya Phrommintikul, Supawan Buranapin, Nipon Chattipakorn, Satawat Thongsawat
Institution: Chiang Mai University
Language: English

Topic: Liver Disease Diagnosis and Treatment
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Keywords: dapagliflozin, SGLT2 inhibitors, type 2 diabetes, non-alcoholic fatty liver disease, hepatic steatosis, visceral fat, weight loss, glycemic control, alanine aminotransferase, adipokines, adiponectin, leptin, TNF-α
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W3167353726
FWCI: 6.688
Cites: 31
Cited by: 111
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security